Stock Info Nets

Independent Financial Information Made Easy

Our AI creates

The Best Stock Graphs and Charts

Youtube Subscribe Blog GamificArt

The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.

July 31, 2023 13:38 (London Time)

AbbVie

Youtube Subscribe

...

Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.9907
MarketCap: 266,143,098,228.0
High: 151.76 Low: 148.56

Open: 149.92 Close: 150.85 Change: 0.93

Are you looking for information about AbbVie? We programmed an AI to summarize it for you.

Are looking for the most relevant information about AbbVie? Investor spend a lot of time searching for information to make investment decisions in AbbVie. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AbbVie are: AbbVie, Humira, sale, stock, year, launch, drug, and the most common words in the summary are: abbvie, stock, market, report, earnings, news, abbv, . One of the sentences in the summary was: In 2022, Abbvies revenue was $58.05 billion, an increase of 3.30% compared to the …

Concept Map

...

Semantic Network

...

Stock Summary

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenos.

Today's Summary

AbbVie Inc. (abbvie inc. (abvv) stock price, quote & news - stock analysis. In 2022, Abbvies revenue was $58.05 billion, an increase of 3.30% compared to the previous years $56.20 billion. The patent cliff is behind the stocks following weeksetz divorce LawUrbanthirst.

Today's News

AbbVie Inc. (abbvie inc. (abvv) stock price, quote & news - stock analysis. In 2022, Abbvies revenue was $58.05 billion, an increase of 3.30% compared to the previous years $56.20 billion. Coherus BioSciences launches biosimilar version of AbbVies blockbuster Humira. Sandoz launches rival version of the blockbuster arthritis drug. Organon, Samsung Bioepis launch copycat for athritis drug Humira at 85% discount. TUP : 3.30 (+7.14%) NVDA : 469.32 (+0.39%) DAL : 45.81 (+0.20%) DB : 11.13 (+0%. AMZN : 133.80 (+1.20%) AAPL : 196.61 (+040%) ABBV : 150.95 (+0 0.07%) The patent cliff is behind the stocks following weeksetz divorce LawUrbanthirst donation foul Phonegrades Neville num AbbVie likely to beat Wall Street sales estimates for Humira in the second quarter as the only copycat in the U.S. Humira sales are likely to decline when the company reports on Thursday but that would mostly be due to the discounts. Risankizumab (SKYRIZI) Met Primary and Key Secondary Endpoints in 52-Week Phase 3 Maintenance Study in Ulcerative Colitis Patients. AbbVie files Patent Infringement Lawsuit against BeiGenes Brukinsa. AbbVie raised its annual profit forecast to $10.90 to $11.10 per share after beating analysts estimates for second-quarter earnings on a lower-than-expected fall in Humira sales. AbbVie announces positive top-line results from INSPIRE, a Phase 3 induction study, showing Skyrizi (risankizumab, 1200 mg intravenous (IV) met the primary endpoint of clinical remission at week 12, as well as all secondary endpoints. These press releases remain on AbbVies website for historical purposes only. Yes link below will take you out of the Abbvie family of websites. Use this information to help you understand our business. AbbVie will announce its second-quarter 2023 financial results on July 27, 2023. The company will host a live webcast of the earnings conference call at 8 a.m. It will be accessible through the companys Investor Relations website. AbbVie is banking on its other immunology drugs Rinvoq and Skyrizi to offset the sales erosion from Humira over the long term. AbbVie has expanded its strategic collaboration with Calibr to advance multiple preclinical and early-stage clinical assets. This partnership represents an extension of the collaboration established by Abbvie in 2019. AbbVie expects full-year earnings in the range of $10.90 to $11.10 per share. Shares have declined 12% since the beginning of the year. AbbVie is raising its adjusted diluted EPS guidance for the full year 2023 from $10.57 - $10.97 to $11.10. The European Medicines Agencies Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending the approval of atogepant for the prophylaxis of migraine.

Stock Profile

"AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq, a JAK inhibitor to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, and ulcerative colitis; Imbruvica for the treatment of adult patients with blood cancers; and Venclexta/Venclyxto to treat hematological malignancies. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; and Ubrelvy for the acute treatment of migraine with or without aura in adults; Qulipta for episodic migraine. In addition, the company offers Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure(IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Restasis, a calcineurin inhibitor immunosuppressant indicated to increase tear production; and eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus (HCV) genotype 1-6 infection and HCV genotype 1 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; I-Mab Biopharma; Genmab A/S; Janssen Biotech, Inc.; and Genentech, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois."

Keywords

The game is changing. There is a new strategy to evaluate AbbVie fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AbbVie are: AbbVie, Humira, sale, stock, year, launch, drug, and the most common words in the summary are: abbvie, stock, market, report, earnings, news, abbv, . One of the sentences in the summary was: In 2022, Abbvies revenue was $58.05 billion, an increase of 3.30% compared to the previous years $56.20 billion. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #abbvie #stock #market #report #earnings #news #abbv.

Read more →

Related Results

...
March 17, 2024 3:57 (London Time)

AbbVie

For the current quarter, Abbvie is expected to post earnings of $2.34 per share, indicating a change of -4.9% from the year-ago quarter. For next fi…
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.9463
MarketCap: 314,220,281,098.0
High: 180.58 Low: 177.54

Open: 179.84 Close: 177.88 Change: -1.96

Read more →
...
March 08, 2024 1:41 (London Time)

AbbVie

AbbVie Inc. closed the most recent trading day at $180.57, moving -0.27% from the previous trading session. Dupixent, the megablockbuster immunology…
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.9678
MarketCap: 319,837,666,380.0
High: 182.42 Low: 179.54

Open: 182.19 Close: 180.57 Change: -1.62

Read more →
...
February 23, 2024 5:53 (London Time)

AbbVie

Richard Gonzalez, who has led the company since it spun out from Abbott Laboratories in 2013, is retiring from the role. He will be replaced by the …
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.9814
MarketCap: 312,224,166,203.0
High: 177.34 Low: 173.14

Open: 174.78 Close: 176.75 Change: 1.97

Read more →
...
February 13, 2024 23:24 (London Time)

AbbVie

AbbVie (ABBV) stock is down -0.12% while the S&P 500 has fallen -1.15% as of 11:57 AM on Tuesday, Feb 13. The pharmaceutical giant had expected to t…
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.9477
MarketCap: 305,561,561,452.0
High: 175.2 Low: 171.96

Open: 174.46 Close: 173.29 Change: -1.17

Read more →
...
February 05, 2024 9:37 (London Time)

AbbVie

Revenues of $54.32 billion, down 5.9% year over year. Sales of oral migraine drug Ubrelvy were $234 million, up 18.9%.
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.9738
MarketCap: 297,793,196,800.0
High: 172.85 Low: 165.23

Open: 169.42 Close: 168.67 Change: -0.75

Read more →
...
January 28, 2024 9:04 (London Time)

AbbVie

AbbVie broke ground on a $223 million expansion of its Singapore manufacturing facility. The project is expected to create more than 100 new jobs an…
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.9826
MarketCap: 290,254,352,012.0
High: 165.86 Low: 163.5

Open: 165.27 Close: 164.4 Change: -0.87

Read more →
...
January 26, 2024 19:24 (London Time)

AbbVie

AbbVie broke ground on a $223 million expansion of its Singapore manufacturing facility. The project is expected to create more than 100 new jobs. T…
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.4019
MarketCap: 291,543,194,329.0
High: 165.81 Low: 163.5

Open: 165.27 Close: 164.17 Change: -1.1

Read more →
...
January 18, 2024 6:40 (London Time)

AbbVie

S&P Futures 4,771.25 0.00 (0.00%) Dow Futures 37,447.00 -11.00 (-0.03%) Nasdaq Futures 16,880.50 +10.75 (+0.75%) Russell 2000 Futures 1,925.80 +0.80…
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.9875
MarketCap: 286,087,683,698.0
High: 162.95 Low: 161.52

Open: 161.75 Close: 162.04 Change: 0.29

Read more →
...
January 17, 2024 23:13 (London Time)

AbbVie

AbbVie Inc. stock falls t Tuesday, underperforms market - marketwatch.com. In 2022, Abbvies revenue was $58.05 billion.
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.9118
MarketCap: 285,098,982,743.0
High: 162.95 Low: 161.52

Open: 161.75 Close: 162.04 Change: 0.29

Read more →
...
January 12, 2024 2:55 (London Time)

AbbVie

Illinois-based drugmaker is not seeing any evidence of sales erosion. Forward dividend yield for AbbVie stock now stands at 3.82%, way below its pre…
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.9603
MarketCap: 291,119,465,348.0
High: 165.12 Low: 163.09

Open: 164.25 Close: 163.78 Change: -0.47

Read more →
...
December 30, 2023 4:56 (London Time)

AbbVie

HSBC downgraded shares of AbbVie from a buy rating to a hold rating. HSBC downgrades shares of ABbV to hold rating on Monday morning. ABbvie possess…
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.9633
MarketCap: 273,605,334,132.0
High: 155.21 Low: 154.41

Open: 154.54 Close: 154.97 Change: 0.43

Read more →
...
December 27, 2023 17:34 (London Time)

AbbVie

AbbVie Inc. has a solid track record of paying dividends. In the last five years, earnings per share has shrunk at approximately 5.3% per annum. The…
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.9005
MarketCap: 272,987,396,035.0
High: 154.97 Low: 153.72

Open: 154.05 Close: 154.51 Change: 0.46

Read more →
...
December 22, 2023 0:58 (London Time)

AbbVie

AbbVie inc. stock rises th Thursday, still underperforms market. The company also started offering healthcare advocacy to all its US employees to he…
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.34
MarketCap: 267,814,371,391.0
High: 152.91 Low: 151.29

Open: 152.05 Close: 152.59 Change: 0.54

Read more →
...
December 18, 2023 4:27 (London Time)

AbbVie

AbbVie Inc. is a pharmaceutical firm with a strong exposure to immunology and oncology. The company announced today that adult patients with relapse…
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.9686
MarketCap: 271,963,384,330.0
High: 155.89 Low: 153.11

Open: 154.74 Close: 154.04 Change: -0.7

Read more →
...
December 07, 2023 2:14 (London Time)

AbbVie

AbbVie is in talks to pay around $45 per share for Cerevel Therapeutics. Cerevel will specifically beef up AbbVsies portfolio for psychiatric and ne…
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.9661
MarketCap: 263,097,858,120.0
High: 147.07 Low: 144.73

Open: 144.79 Close: 146.38 Change: 1.59

Read more →
...
November 27, 2023 5:00 (London Time)

AbbVie

Upadacitinib (RINVOQ®) Met the Primary Endpoint in Phase 2 Clinical Trial of Vitiligo. Upadadacinib has a market cap of $244.82 billion.
Sector: Biotechnology
Ticker: ABBV
Sentiment: -0.8126
MarketCap: 244,827,074,170.0
High: 140.08 Low: 138.46

Open: 140.0 Close: 138.67 Change: -1.33

Read more →
...
November 07, 2023 4:50 (London Time)

AbbVie

AbbVie Inc. is celebrating the fifth annual BOTOX® Cosmetic (onabotulinumtoxinA) Day is Back Like Never Before. The company raised its annual profit…
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.902
MarketCap: 249,293,883,845.0
High: 142.37 Low: 140.98

Open: 141.89 Close: 141.2 Change: -0.69

Read more →
...
November 07, 2023 0:05 (London Time)

AbbVie

Investors in AbbVie (NYSE:ABBV) have seen solid returns of 101% over the past five years. Investors in ABbVies earnings per share are down 5.3% per …
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.8909
MarketCap: 249,612,901,485.0
High: 142.37 Low: 140.98

Open: 141.89 Close: 141.2 Change: -0.69

Read more →
...
October 27, 2023 19:21 (London Time)

AbbVie

AbbVie expects full-year earnings in the range of $11.19 to $11.23 per share. Upadacitinib has been approved in the United States for use in seven i…
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.9801
MarketCap: 256,284,777,936.0
High: 143.0 Low: 136.03

Open: 138.77 Close: 137.27 Change: -1.5

Read more →
...
October 16, 2023 1:03 (London Time)

AbbVie

AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply endorsement of the linked sites. The Yes l…
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.9862
MarketCap: 261,156,306,772.0
High: 149.66 Low: 147.34

Open: 148.95 Close: 147.96 Change: -0.99

Read more →
...
October 10, 2023 15:36 (London Time)

AbbVie

AbbVie Inc. (ABBV) stock price, quote, news & analysis. Use the Yes link below to take you out of the Abbvie family of websites. The inclusion of an…
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.9809
MarketCap: 263,186,110,454.0
High: 149.54 Low: 148.04

Open: 149.39 Close: 148.78 Change: -0.61

Read more →
...
September 30, 2023 8:35 (London Time)

AbbVie

AbbVie Inc. stock falls t Tuesday, still outperforms market - marketwatch.com. European Commission grants conditional marketing authorization for TE…
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.9824
MarketCap: 263,097,858,120.0
High: 152.53 Low: 148.83

Open: 152.46 Close: 149.06 Change: -3.4

Read more →
...
September 15, 2023 0:13 (London Time)

AbbVie

AbbVie Inc. stock has fallen -0.05% while the S&P 500 gained as of 10:56 AM on Monday, Sep 11. Skyrizi (risankizumab) met the primary and key second…
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.9959
MarketCap: 266,804,456,148.0
High: 154.69 Low: 151.81

Open: 152.01 Close: 153.64 Change: 1.63

Read more →
...
August 31, 2023 5:00 (London Time)

AbbVie

AbbVie stock price is 11324% away from the 52-week low. The analysts have a median target of 16240, with a median of a high estimate of 200.00. The …
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.9856
MarketCap: 261,791,723,577.0
High: 148.8 Low: 146.9

Open: 148.12 Close: 148.32 Change: 0.2

Read more →
...
August 27, 2023 3:11 (London Time)

AbbVie

AbbVie trades on the NYSE under the ticker symbol ABBV. The company trades on NYSE. If you had invested in Abbvie stock at $35.12 in 2013, your retu…
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.9935
MarketCap: 258,914,697,489.0
High: 147.67 Low: 146.2

Open: 147.02 Close: 146.69 Change: -0.33

Read more →
...
August 07, 2023 13:24 (London Time)

AbbVie

European Commission approved Rinvoq (upadacitinib, 45 mg induction dose, 15 mg and 30 mg maintenance doses) as the first oral Janus Kinase (JAK) inh…
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.9902
MarketCap: 262,067,589,067.0
High: 150.57 Low: 147.16

Open: 148.97 Close: 147.73 Change: -1.24

Read more →
...
July 31, 2023 13:38 (London Time)

AbbVie

AbbVie Inc. (abbvie inc. (abvv) stock price, quote & news - stock analysis. In 2022, Abbvies revenue was $58.05 billion, an increase of 3.30% compar…
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.9907
MarketCap: 266,143,098,228.0
High: 151.76 Low: 148.56

Open: 149.92 Close: 150.85 Change: 0.93

Read more →
...
July 27, 2023 2:19 (London Time)

AbbVie

AbbVie Inc. (ABBV) may see less pain from Humira sales decline as rival lags. The company is banking on its other immunology drugs Rinvoq and Skyriz…
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.9531
MarketCap: 250,352,705,592.0
High: 142.28 Low: 140.52

Open: 141.43 Close: 141.9 Change: 0.47

Read more →
...
July 21, 2023 5:34 (London Time)

AbbVie

AbbVie (ABBVie) is attracting investor attention: here is what you should know. The company is expected to post earnings of $2.92 per share for the …
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.9769
MarketCap: 250,864,349,599.0
High: 142.72 Low: 138.55

Open: 138.84 Close: 142.19 Change: 3.35

Read more →
...
July 13, 2023 17:43 (London Time)

AbbVie

Dillards, Suzano, Atkore, Nexstar Media Group and AbbVie are part of the Zacks Screen of the Week article. Dillards (DDS), Suzano (SUZ), Atkore (ATK…
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.7114
MarketCap: 238,143,821,006.0
High: 134.1 Low: 132.72

Open: 132.93 Close: 133.5 Change: 0.57

Read more →
...
June 26, 2023 19:40 (London Time)

AbbVie

AbbVie stock sinks 5.1% premarket after Q1 profit missed expectations. European Commission approved Rinvoq as the first oral Janus Kinase (JAK) inhi…
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.9828
MarketCap: 239,802,253,305.0
High: 135.9 Low: 133.69

Open: 136.15 Close: 135.28 Change: -0.87

Read more →
...
June 17, 2023 10:02 (London Time)

AbbVie

AbbVie is focused on strengthening its focus on new immunology medicines, Skyrizi and Rinvoq. Last month, the FDA approved JAK inhibitor RINVOq for …
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.9876
MarketCap: 244,601,121,235.0
High: 138.92 Low: 136.49

Open: 136.7 Close: 138.64 Change: 1.94

Read more →
...
May 30, 2023 3:52 (London Time)

AbbVie

AbbVie stock (ABBV) is a better pick than its industry peer, Eli Lilly stock (LLY) LLY stock trades at a higher valuation of 14.6x trailing revenues…
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.9861
MarketCap: 267,479,177,744.0
High: 139.85 Low: 137.1

Open: 138.72 Close: 137.56 Change: -1.16

Read more →
...
May 21, 2023 5:54 (London Time)

AbbVie

AbbVie Inc. (ABBV) has been one of the stocks most watched by Zacks.com users lately. The company has gained 64% since 2019 primarily due to favorab…
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.9977
MarketCap: 267,479,177,744.0
High: 145.8 Low: 143.8

Open: 143.86 Close: 145.11 Change: 1.25

Read more →
...
May 04, 2023 14:43 (London Time)

AbbVie

The average analyst consensus on ABBV stock is a Moderate Buy. The company beat sales expectations with revenue of $12.23 billion, topping estimates…
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.8927
MarketCap: 260,828,119,040
High: 149.03 Low: 147.68

Open: 149.0 Close: 147.85 Change: -1.15

Read more →
...
May 01, 2023 15:39 (London Time)

AbbVie

Revenue at North Chicago-based Abbvie dove by nearly 10% during the first few months of this year. AbbVie expects full-year earnings in the range of…
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.9879
MarketCap: 269,878,132,736
High: 154.16 Low: 150.82

Open: 150.84 Close: 152.98 Change: 2.14

Read more →
...
April 22, 2023 6:39 (London Time)

AbbVie

AbbVie is a pharmaceutical giant that is building out its portfolio to look nothing like it did a decade ago. The company generated FCF of $24.2 bil…
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.988
MarketCap: 286,513,987,584
High: 163.19 Low: 162.02

Open: 162.59 Close: 162.41 Change: -0.18

Read more →
...
March 10, 2024 2:30 (London Time)

AbbVie

AbbVie CF Scholarship winners will each be awarded a total of $25,000. President and COO Robert Michael will take over Richard Gonzalezs CEO duties.
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.9072
MarketCap: 315,933,760,257.0
High: 182.14 Low: 178.68

Open: 179.74 Close: 178.85 Change: -0.89

Read more →
...
February 24, 2024 5:46 (London Time)

AbbVie

AbbVie CEO Richard Gonzalez will step down July 1. He will be replaced by the companys current president and chief operating officer Robert Michael.…
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.9817
MarketCap: 314,591,240,504.0
High: 178.91 Low: 177.01

Open: 177.26 Close: 178.09 Change: 0.83

Read more →
...
February 21, 2024 9:33 (London Time)

AbbVie

Robert Michael, AbbVies president and chief operating officer, will become CEO on July 1. Robert Michael will succeed Richard Gonzalez, who has led …
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.8932
MarketCap: 310,293,201,740.0
High: 178.68 Low: 175.52

Open: 175.83 Close: 175.75 Change: -0.08

Read more →
...
February 09, 2024 1:30 (London Time)

AbbVie

Skyrizi and Rinvoq as top TV drug ad spender in 2023. UK National Institute for Health and Care Excellence recommended Tepkinly as a third-line trea…
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.9861
MarketCap: 308,986,704,049.0
High: 175.91 Low: 174.3

Open: 174.35 Close: 174.79 Change: 0.44

Read more →
...
January 30, 2024 2:48 (London Time)

AbbVie

AbbVie broke ground on a $223 million expansion of its Singapore manufacturing facility. The project is expected to create more than 100 new jobs an…
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.9633
MarketCap: 290,254,352,012.0
High: 166.76 Low: 163.68

Open: 165.85 Close: 163.91 Change: -1.94

Read more →
...
January 26, 2024 21:48 (London Time)

AbbVie

AbbVie broke ground on a $223 million expansion of its Singapore manufacturing facility. The project is expected to create more than 100 new jobs an…
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.9842
MarketCap: 291,543,194,329.0
High: 165.86 Low: 163.5

Open: 165.27 Close: 164.4 Change: -0.87

Read more →
...
January 23, 2024 2:45 (London Time)

AbbVie

AbbVie Inc. is committed to operating with integrity, driving innovation, transforming lives, serving our community, and embracing diversity and inc…
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.9926
MarketCap: 290,907,600,858.0
High: 165.45 Low: 163.76

Open: 164.44 Close: 165.39 Change: 0.95

Read more →
...
January 18, 2024 2:34 (London Time)

AbbVie

CVS Health said on Wednesday it will remove Abbvies blockbuster rheumatoid arthritis drug Humira from some of its lists of preferred drugs for reimb…
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.9855
MarketCap: 285,098,982,743.0
High: 162.95 Low: 161.52

Open: 161.75 Close: 162.04 Change: 0.29

Read more →
...
January 16, 2024 13:47 (London Time)

AbbVie

AbbVie Inc. is one of the stocks most watched by Zacks.com visitors lately. The company is expected to post earnings of $2.93 per share in the curre…
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.9915
MarketCap: 286,723,277,170.0
High: 163.3 Low: 162.18

Open: 162.75 Close: 162.4 Change: -0.35

Read more →
...
January 10, 2024 18:04 (London Time)

AbbVie

CVS Health said on Wednesday it will remove Abbvies blockbuster rheumatoid arthritis drug Humira from some of its lists of preferred drugs for reimb…
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.9825
MarketCap: 286,564,378,802.0
High: 164.95 Low: 161.9

Open: 162.27 Close: 163.64 Change: 1.37

Read more →
...
December 27, 2023 18:20 (London Time)

AbbVie

HSBC downgraded shares of AbbVie from a buy rating to a hold rating in a research report sent to investors on Monday morning. HSBC cut its holdings …
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.9157
MarketCap: 272,987,396,035.0
High: 154.97 Low: 153.72

Open: 154.05 Close: 154.56 Change: 0.51

Read more →
...
December 25, 2023 17:49 (London Time)

AbbVie

Average price target for AbbVie is $169.00, which is 9.07% higher than the current price. HSBC Analyst Rajesh Kumar downgrades Abbvie from Buy to Ho…
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.91
MarketCap: 273,552,368,009.0
High: 155.46 Low: 153.09

Open: 153.29 Close: 154.94 Change: 1.65

Read more →
...
December 19, 2023 0:11 (London Time)

AbbVie

AbbVie announced the acquisition of Cerevel Therapeutics in $8.7 billion all-cash deal. Q4 earnings are confirmed for Thursday, February 8, 2024. Th…
Sector: Biotechnology
Ticker: ABBV
Sentiment: -0.765
MarketCap: 271,963,384,330.0
High: 154.35 Low: 151.75

Open: 153.0 Close: 153.42 Change: 0.42

Read more →
...
December 16, 2023 21:09 (London Time)

AbbVie

Goldman Sachs upgraded the pharma giant to Buy from Neutral with a 12-month price target of $173. AbbVie currently Up 11 Consecutive Days, on Pace f…
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.9849
MarketCap: 271,963,384,330.0
High: 155.89 Low: 153.11

Open: 154.74 Close: 154.04 Change: -0.7

Read more →
...
December 05, 2023 6:29 (London Time)

AbbVie

AbbVie has agreed to acquire ImmunoGen and its first-in-class antibody-drug conjugate (ADC) ELAHERE (mirvetuximab soravtansine-gynx) for $10.1 billi…
Sector: Biotechnology
Ticker: ABBV
Sentiment: -0.7845
MarketCap: 254,502,219,237.0
High: 145.49 Low: 143.27

Open: 143.41 Close: 144.15 Change: 0.74

Read more →
...
November 19, 2023 3:58 (London Time)

AbbVie

12 stock analysts on Stockchase covered Abbvie Inc. On 2023-11-17, the company will be worth watching. The current AbbVie [ ABBV ] share price is $1…
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.9781
MarketCap: 244,173,825,324.0
High: 138.88 Low: 137.38

Open: 138.36 Close: 138.3 Change: -0.06

Read more →
...
November 07, 2023 1:05 (London Time)

AbbVie

Investors in AbbVies TSR for the last 5 years was 101% which exceeds the share price. Reddys (RDY), Novo Nordisk (NVO), and Ab
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.9559
MarketCap: 249,612,901,485.0
High: 142.37 Low: 140.98

Open: 141.89 Close: 141.2 Change: -0.69

Read more →
...
October 29, 2023 0:24 (London Time)

AbbVie

AbbVie expects full-year earnings in the range of $11.19 to $11.23 per share. CEO Rich Gonzalez says company was aware of potential for an ADC trans…
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.9398
MarketCap: 245,217,935,252.0
High: 143.0 Low: 136.03

Open: 138.77 Close: 138.93 Change: 0.16

Read more →
...
October 24, 2023 4:16 (London Time)

AbbVie

AbbVie (ABBV) closed at $144.73, marking a -1.03% move from the previous day. The company currently carries a Zacks Rank #3. Abbvie recast historica…
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.9319
MarketCap: 255,455,205,996.0
High: 146.42 Low: 144.2

Open: 146.16 Close: 144.73 Change: -1.43

Read more →
...
October 16, 2023 0:23 (London Time)

AbbVie

AbbVie Inc. (ABBV) stock price, quote & news - stock analysis. Analyst Consensus: Buy Stock Forecasts. Price Target $169.88 (14.82% upside)
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.9843
MarketCap: 261,156,306,772.0
High: 149.66 Low: 147.34

Open: 148.95 Close: 147.96 Change: -0.99

Read more →
...
October 07, 2023 7:32 (London Time)

AbbVie

AbbVie Inc. stock is lower by -1.78% while the S&P 500 has fallen by 1.49% as of 11:47 AM on Tuesday, Oct 3. Abbvie has acquired discovery-stage bio…
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.3691
MarketCap: 261,650,519,843.0
High: 149.33 Low: 146.12

Open: 146.49 Close: 148.24 Change: 1.75

Read more →
...
September 20, 2023 4:03 (London Time)

AbbVie

PBM officials say PBMs persuaded Abbvie to increase its Humira rebates. Company appears to be terminating development of two Phase I antibody-drug c…
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.9573
MarketCap: 270,917,014,913.0
High: 154.64 Low: 151.6

Open: 153.89 Close: 153.49 Change: -0.4

Read more →
...
September 01, 2023 7:26 (London Time)

AbbVie

AbbVie (ABBV) stock has fallen -0.5% while the S&P 500 is up 0.84% as of 11:13 AM on Tuesday, Aug 29. The Street downgraded Abbvie from a “b-” ratin…
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.994
MarketCap: 259,391,260,092.0
High: 148.71 Low: 146.87

Open: 148.39 Close: 146.96 Change: -1.43

Read more →
...
August 27, 2023 5:42 (London Time)

AbbVie

AbbVie Inc. is one of the stocks most watched by Zacks.com visitors lately. For the current quarter, Abbvie is expected to post earnings of $2.87 pe…
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.974
MarketCap: 258,914,697,489.0
High: 147.67 Low: 146.2

Open: 147.02 Close: 146.69 Change: -0.33

Read more →
...
August 22, 2023 4:13 (London Time)

AbbVie

European Commission approves AQUIPTA for the prophylaxis of migraine in adults who have four or more migraine days per month. European Commission ap…
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.96
MarketCap: 265,004,108,535.0
High: 150.35 Low: 148.88

Open: 149.71 Close: 150.16 Change: 0.45

Read more →
...
August 05, 2023 14:48 (London Time)

AbbVie

European Commission approved Rinvoq as the first oral Janus Kinase (JAK) inhibitor for the treatment of adult patients with Crohns disease. Teva Pha…
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.9857
MarketCap: 262,067,589,067.0
High: 150.57 Low: 147.16

Open: 148.97 Close: 147.73 Change: -1.24

Read more →
...
July 28, 2023 0:38 (London Time)

AbbVie

RINVOQ is a selective JAK inhibitor that is being studied in several immune-mediated inflammatory diseases. European Medicines Agencies Committee fo…
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.9557
MarketCap: 250,352,705,592.0
High: 151.37 Low: 144.12

Open: 144.48 Close: 148.85 Change: 4.37

Read more →
...
July 24, 2023 16:03 (London Time)

AbbVie

AbbVie closed the most recent trading day at $137.68, moving +0.81% from the previous trading session. The companys next earnings release is expecte…
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.969
MarketCap: 253,598,998,603.0
High: 144.43 Low: 142.84

Open: 143.1 Close: 143.72 Change: 0.62

Read more →
...
July 18, 2023 20:31 (London Time)

AbbVie

Abbvie Inc. will announce its second-quarter 2023 financial results on Thursday, July 27, 2023, before the market opens. Dillards, Suzano, ATKore, N…
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.8074
MarketCap: 237,879,177,554.0
High: 137.9 Low: 134.71

Open: 134.8 Close: 136.58 Change: 1.78

Read more →
...
June 30, 2023 16:47 (London Time)

AbbVie

AbbVie Inc (ABBV) stock is down -1.49% while the S&P 500 has risen 1.15% as of 3:04 PM on Tuesday, Jun 27. European Medicines Agencies Committee for…
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.9705
MarketCap: 233,944,811,568.0
High: 135.93 Low: 132.8

Open: 133.47 Close: 135.05 Change: 1.58

Read more →
...
June 25, 2023 9:36 (London Time)

AbbVie

Wall Street analysts forecast ABBV stock price to rise over the next 12 months. Board of directors has increased its dividend by 270 percent since i…
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.9907
MarketCap: 239,802,253,305.0
High: 138.69 Low: 135.67

Open: 137.3 Close: 135.92 Change: -1.38

Read more →
...
June 03, 2023 14:16 (London Time)

AbbVie

AstraZeneca (AZN.L) said on Thursday it would stop developing its drug brazikumab. AbbVie stock forecasts short-term for next days and weeks may dif…
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.2665
MarketCap: 235,426,814,899.0
High: 136.97 Low: 133.5

Open: 133.71 Close: 136.87 Change: 3.16

Read more →
...
May 23, 2023 3:03 (London Time)

AbbVie

AbbVie Inc. reported revenues of $12.23 billion in the last reported quarter, representing a year-over-year change of -9.7%.
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.9353
MarketCap: 267,479,177,744.0
High: 146.66 Low: 143.78

Open: 145.47 Close: 144.9 Change: -0.57

Read more →
...
May 10, 2023 9:59 (London Time)

AbbVie

Guggenheim has decided to maintain their Buy rating on Abbvie, which currently sits at a price target of $171.00. Morgan Stanley has decided AbbVie …
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.9874
MarketCap: 267,479,177,744.0
High: 148.46 Low: 146.27

Open: 147.41 Close: 146.83 Change: -0.58

Read more →
...
May 03, 2023 22:57 (London Time)

AbbVie

AbbVie Inc. reports 9.7% fall in global net revenues for q1 2022. The company trimmed its full-year profit expectations earlier this month by 8 cent…
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.9843
MarketCap: 263,297,892,352
High: 151.51 Low: 148.45

Open: 151.07 Close: 149.25 Change: -1.82

Read more →
...
April 28, 2023 19:21 (London Time)

AbbVie

AbbVie beat sales expectations with revenue of $12.23 billion, topping estimates of $13.17 billion. European Commission Approval of RINVOQ for the T…
Sector: Biotechnology
Ticker: ABBV
Sentiment: 0.9813
MarketCap: 266,120,527,872
High: 151.39 Low: 147.45

Open: 147.97 Close: 150.85 Change: 2.88

Read more →